DelveInsight's "YUTIQ Market Size, Forecast, and Market Insight Report" highlights the details around YUTIQ, a sterile ...

Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The uveitis treatment market is projected to grow steadily ...

About OCS-01 eye drops and the OPTIREACH® technology Leveraging Oculis’ proprietary technology, OCS-01 is an OPTIREACH® formulation of high concentration dexamethasone eye drop. It is being ...

Leveraging Oculis' proprietary technology, OCS-01 is an OPTIREACH ® formulation of high concentration dexamethasone eye ... limitations of conventional eye drops by improving the solubility ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

ACULAR LS eye drops, solution 0.4% Allergan ACULAR PRESERVATIVE FREE eye drops, solution 0.5% Allergan AKBETA eye drops, solution 0.25% Akorn Inc. AKBETA eye drops, solution 0.5% Akorn Inc.

Leveraging Oculis’ proprietary technology, OCS-01 is an OPTIREACH ® formulation of high concentration dexamethasone eye drop ... addresses the main limitations of conventional eye drops by improving ...

Anti-Inflammatory Inside and Out Originally embraced in dermatology clinics for anti-aging, red light therapy (RLT) has found ...